Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Robwilly.
I fully agree here, however I think we might get a better conversion rate then that, the fact that the 20 mil tax loss is now going to follow LTC, I think that was done in order to obtain a higher % ownership of LTC for existing CTGI holders, remember the board is heavily invested here themselves, so one must assume that they will cut the best possible deals for shareholders, I am hoping for a 5 to 1 conversion myselves, for every 100.000 turning into 20000 LTC shares, however my target for the LTC price per share is around $1, so based on that CTGI should presently be worth $0.20 per share without taken into account CCTI, undervalued here IMO.
GLTA.
A.H
Don't have margin at all, and yes you can be sure I will call my broker, money was there in cash to buy so really no excuse for not filing, I am absolutely furious and will call them first thing tomorrow when market is open, will push them to give me my shares, then it is up to them to find them in the market at that price.
GLTA.
A.H
Put an order in today before leaving for work for 10000 @ 0.70, seeing that it traded at 0.70 and the bid is now 0.66 I assumed that my order was filled, however I called my dad and got him to check my account, and it states the order has been rejected, now how is that for manipulation. that has never happened to me on any other stock, they obviously needed to get my bid out of the way so that they can show a much lower bid. can't wait for them to get this permit so all the manipulators can fry.
GLTA.
A.H
Ok. No worries.
GLTA.
A.H
Well it has never done that for other pinks before. so seems quite strange.
GLTA.
A.H
What's going on with the volume here, I am at work and can't get streaming quotes on my work pc, I have an ameritrade account, and on the bottom of the page they have a small quote box that updates quotes for one symbol every time you click on it.
Today at one point when I updated, the volume showed 58000, 10 min later when I clicked again, it only showed 48000.
Same thing happened Monday, at one point it showed 110000, 10-15 min later only 70000 or there abouts, anybody else experienced the same thing or?
Very strange indeed, have never seen this before, and have used this ameritrade account for a couple of years.
GLTA.
A.H
also consider this, sales people are paid commision up front for their sales, however revenue is not booked by the company until they are fairly certain payment will be met.
See notes fom Q10.
The Company recognizes revenue when each of the following four conditions are met: 1) a contract or sales arrangement exists; 2) products have been shipped and title has transferred or rental services have been rendered; 3) the price of the products or services is fixed or determinable; and 4) collectibility is reasonably assured. Accordingly, the Company recognizes revenue, both rental and sales, when products have been dispensed to the patient and the patient’s having insurance has been verified. For medical products that are sold from inventories consigned at clinic locations, the Company recognizes revenue when it receives notice that the product has been prescribed and dispensed to the patient and the patient’s having insurance has been verified or preauthorization has been obtained from the insurance company, when required. Revenue from the rental of products is normally on a month-to-month basis and is recognized ratably over the products’ rental periods. Products on rental contracts are accounted for as property and equipment on the Company’s balance sheet and depreciated over their estimated useful life. All revenue is recognized at amounts estimated to be paid by customers or third party payors using the Company’s established rates, net of estimated discounts. The Company recognizes revenue from distributors when it ships its products fulfilling an order and title has transferred.
The company has employed alot of sales people in the last 6 months, which have increased sales, Which I believeis one of the reasons AR has increased to currently 6.2 mil, I expect some of this will be recognized as revenue in the coming quarters, and hopefully start hitting the bottom line.
Thanks, just got through, but can't be bother hanging on the line for an hour.
GLTA.
A.H
Thanks
Is the conference call now, or in an hour.
GLTA.
A.H
Ecomike.
Thanks for clearing that up.
GLTA.
A.H
Very good news today, I have been following this company for a while and today's news were yet one more step in the right direction, will be interesting to see the proto type when finished, and also see some numbers in regards to how much it will cost to make oil from CO2.
Another green company of interest here is JBII, which can turn Plastic into oil at $10 a barrel, according to the CEO, they a much closer to commercialisation, as the plant is ready, all they need is a stack test, which is already scheduled in, and then an air permit, after which they should be ready to sell fuel, stock price currently low due to the company restating last 2 quarters by their own choice, message board full of bashers as well.
Still do a little DD, and I sure you will find it interesting.
GLTA.
A.H
Maddogs.
Thanks for clarifiring.
GLTA.
A.H
So what about the 8 mill owed to Jessup and lamont by CTGI. what happens to them.
GLTA.
A.H
Dokkey.
Sorry no I am scratching my head as well. However normally a huge volume points to more action in the stock price either up or down.
But does seem very weird in such a thinly traded stock.
GLTA.
Alex
That was a huge volume today, hopefully that is a sign that this stock is going to start to move. Feel that it is quite undervalued at these prices.
GLTA.
A.H
Out of funds as well, just wanted a small position here as the risk/reward looked good. Good luck and lets hope the 2nd quarter numbers are better then 1st quarter. Hoping to see a PR regarding the law suit in the near future as well.
GLTA.
A.H
Penn33c
Thanks for posting the link anyway, if it is dismissed then we should see a PR from the company soon. I have wanted to buy into this company for a while now, and finally pulled the trigger today and bought 8000 @ 0.60, figure that it will come up at some point and $0.60 seems to be quite near the bottom for this stock.
did you manage to get any.
GLTA.
A.H
Thats great news, if I am right in understanding the suit as being dismissed.
GLTA.
A.H
Eiddle.
Thanks.
GLTA
A.H
Hi.
Have been following this company for a while, and read a lot of the great info being postet here, however I seem to remember somebody postet some info that CABN would now be able to convert the CO2 in the smoke gas directly into fuel without sequesting the CO2 first, does anybody remember this and have a link they could post.
TIA.
A.H
Wow.
Was this the final flush out, I sure hope so, volume was several times normal volume over the last two days, crossing my fingers here hoping that this was the bottom and that we can now start to move up from here.
GLTA.
A.H
Ninja.
I took the liberty of forwarding this suggestion to the company,hope you don't mind, and they have signed up and re-released the news through them today, have any of you guys seen the re-release on any of their news wires, then please mention it here on ihub, don't have time to check as I am at work for the next many hours.
GLTA.
A.H
Lowman.
Thanks, let me know what Bruce thinks about the idea, will call him myself next week as well.
GLTA.
A.H
Ninja.
That is a very good idea. Have you put this suggestion forward to the Company, I would happily pay for the subscription, if we could get the PR released again, fully updated with ticker symbol and maybe a short line that the company is working hard on getting the financial reports filed as well. let me know your thoughts.
GLTA.
A.H
I don't think MM's are showing any orders below 5000 shares on OTC stocks.
GLTA.
A.H
Mike.
Once again thank you very much, much appreciated, I am watching ASRG everyday, will probably take a position shortly.
GLTA.
A.H
Does anybody know when they are scheduled to release yearly results.
GLTA.
A.H
Does anybody know when the 10K is coming out.
GLTA.
A.H
240.000 shares sold I assume you mean.
GLTA.
A.H
Patrick Cox who runs the breakthrough Technology newsletter is actually quite good, had a years subscription with this service and found it very informative, breakthrough technology within the medical world is what he specialises in, especially stem cell companies, he recommended BTIM around 8 months ago, it was his strongest buy recommendation back then, that has since shot up around 500%. I don't know how strong a buy recommendation he has on this stock as I haven't read the report.
GLTA.
A.H
The directors have in recent time added the following amount of shares.
DERDEYN CONRAD 121,253
MACHEN ROBERT 2,476,993
Robbins Donald. S 5,802,218
Jones Bruce K 146,667
Total 8,547,131.
Add to that the 2 mill issued to Greenblatt and we end up with a total of 10,547,131.
Add to that the shares we had outstanding as of the last quarterly report 09/30/2008.
Common stock, par value $0.001 per share, 80,000,000 shares authorized and 39,919,375 and 38,018,544 issued and outstanding
And we end up with a total O/S in the region of 50 mill.
Does other people come up with the same number?
GLTA.
A.H
Excuse me. Now you did it! Lowman is right this is his office number, I have personally called Bruce on this number many times over the last 3 years, and it is his office number, whenever he is not there, I get the message “sorry I am not in the office right now, please leave a message and I will get back to you”
the fact that he just say hello does not in any way prove that it is a mobile. Please prove your drivel before posting it on the message boards thanks.
GLTA.
A.H
ZYXI is pushing hard today. up 19.4% to $1,60 HOD $1,72. volume can go a lot higher.
GLTA.
A.H
RGCI sold for 0.79
WOW I didn't mean for you guys to rush in and sell your RGCI LOL.
GLTA.
A.H
RGCI started to move. up 9% to 0.62.
GLTA.
A.H
Question for the board, in the 8K it states the following.
On September 22, 2009 the Registrant ("CSMG") entered into a Settlement Agreement and Mutual Release (the "Settlement Agreement") with Banco Panamericano ("Banco") and Leon A. Greenblatt, President and CEO of Banco, pursuant to which Banco assigned to Donald A. Robbins, President of CSMG, the judgment it had obtained against CSMG on December 23, 2008 in the case styled Banco Panamericano v. Consortium Service Management Group. Inc., Case No. 07-C 15, in the Northern District of Illinois District Court, in the amount of $726,491.91 plus attorney's fees of $474,828.46 or a total of $1,201,320.37. Under the terms of the Settlement Agreement, CSMG transferred to Banco 2,000,000 restricted shares of its common stock, its CO2 scrubber, one patent related to the CO2 scrubber and certain other consideration.
How is it possible for DR to personally acquire the judgement, when shares, patent and the CO2 scrubber were issued from CTGI, which is owned by shareholders, surely the judgement should now belong to CTGI, I hope that somebody can cast some light on this.
GLTA
A.H
found this from another board, think this write up is why there is a huge buying interest today in ISCO.
ISCO's Parthenogenic Patent Strength
International Stem Cell, as I've explained before, holds all the major patents regarding parthenogenic stem cells (hpSCs). This alone makes the company worthy of investors' attention. Virtually every other stem cell company will share some future revenues, at least, with the Wisconsin Alumni Research Foundation, holder of certain basic SC patents. Moreover, ISCO already has an established laboratory supply business, Lifeline Cell Technology, that is on track to cover the expenses for the entire company. This is NOT a struggling company.
The big deal about ISCO, however, is its parthenogenic stem cell technology. These cells are derived from unfertilized ovum. They have only half the normal DNA and are, therefore, much, much easier to HLA match to minimize or eliminate immune reactions. They also have a huge near-term marketing advantage in that these cells have nothing to do with embryos and are, therefore, more acceptable to consumers who have ethical objections to the use of cells that could theoretically become embryos.
Of course, with the rise of iPS technologies, virtually any cell in your body could be transformed into an embryo. That, however, is a story I don't have the time or space to deal with today, though it is a fascinating story.
HLA, incidentally, is the acronym for human leukocyte antigens. These antigens determine how your body will respond to transplanted tissue. A close HLA match with a donor assures that transplants are well tolerated. A poor match can result in rejection or require significant immune system suppression, which has all kinds of undesirable side effects.
I think that induced pluripotent stem (iPS) cells are destined to be the “Cadillac” of stem cell treatments. A little of your blood can be used to produce stem cells that exactly match your body, provoking no immune reaction. For some time, however, iPS cells will be high-end therapies and relatively expensive.
The advantage that hpSCs have is that they hold the promise of cheap “off-the-shelf” therapies for a wide range of critical medical conditions. ISCO is working on hpSCs for renal failure, macular degeneration and severe diabetes. The company expects to enter clinical testing for macular degeneration soon. In the long term, they it also plans to produce cells for more dramatic therapies such as heart and vascular tree rejuvenation.
The genius of hpSC technology is that scientists believe it is possible to HLA match 99% of the world's population with a limited number of cell donors. Between 50-100 donors could provide the raw materials that would allow the mass production of incredibly powerful stem cell therapies that require little or no immune suppression. Even when iPS cell technology is developed and automated, in fact, I believe the market for these mass-market SC therapies will remain huge for decades.
Clearly, we're not quite there yet. ISCO needs more time, money and FDA approval. In the short run, however, the company has developed several important strategies for continuing growth.
One, as I mentioned above, is Lifeline. Another product, which has produced huge enthusiasm, is a skin stem cell growth media that ISCO scientists accidentally discovered to be an incredibly effective “cosmeceutical.” To the disappointment of many, ISCO has slowed the development process of this product to assure its safety and efficacy, but CEO Ken Aldrich tells me he expects to see it sold to clinics, at least, by Q1 next year.
Now, ISCO has announced another potential near- to midterm revenue blockbuster. As I've told you before, ISCO can already grow perfectly formed human corneas in petri dishes. Eventually, these corneas should provide hundreds of millions in revenues from the international market, where there are desperate shortages of transplant corneas.
ISCO is on track to filling another huge eye-related market. I'm talking about live animal drug and cosmetics testing.
As you probably know, many drugs and cosmetics are safety tested on the eyes of live animals. This is not only an incredibly expensive process, requiring facilities for breeding and taking care of animals, but it is extremely unpopular with consumers. While necessary, no one likes to think about the bunnies in bondage having potentially dangerous, damaging and painful chemicals put in their eyes. Neither, in fact, do the technicians who actually perform the tests.
ISCO's alternative is to provide actual human eye cells. These artificial eyes would not only have more accurate responses to substances than rabbits and other non-human subjects, they are far less expensive and experience no pain. The company is collaborating with a major provider of biological assay system, Absorption Systems, to get its artificial hpSC corneas pre-approved by the FDA and ready for market.
According to the press release, “The collaboration between the companies is focused on using Absorption Systems’ know-how in creating assay systems to develop superior preclinical methods of testing drugs. Such methods can also reduce the use of laboratory animals currently necessary for other tests, including the very large global commercial need for a reliable and reproducible non-animal method for eye safety testing of consumer products.
“In the past, researchers have grown corneal cells in the laboratory, but ISCO is believed to be the only company to grow a self-assembling corneal construct from parthenogenetic stem cells that is suitable for toxicity testing and possibly suitable for corneal transplants. ISCO’s corneal constructs include cell layers and structures normally found in a human cornea, as confirmed by an independent third-party laboratory.”
Let me be clear. This testing market is worth hundreds of millions of dollars. ISCO is not predicting how long it will take to get its alternative to live animal testing validated by the FDA, but I can't believe the administration will resist this product. I really don't think it will take “years,” simply because of the politics involved. Even the providers of live animals want an alternative to the current technology, because of consumer disapproval of their current testing methods.
If the FDA dared drag its feet on this issue, a phone call to PETA could turn this story into a high-profile political issue that no administration would want to deal with. I consider ISCO's decision to pursue this short-term product more evidence that this brilliantly run company will thrive until it can offer the really revolutionary products, including off-the-shelf SC injections that cure pancreatic, liver and heart disease.
Best of all, ISCO's stock prices have dipped recently, and for no detectable reason. This is a perfect opportunity for people who failed to buy when I first recommended the stock.